Identity
- Security key
- 17629
- Ticker
- KAPA
- Type
- CS — Common Stock
- Exchange
- NYSE American, LLC(XASE)
- Venue group
- NYSE
- Operating MIC
- XNYS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2024-09-16
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- KAPA
Detail
Enriched 2026-08-14 20:47
- Market cap
- $7,592,410.81
- Shares outstanding (class)
- 21,411,198
- Shares outstanding (weighted)
- 21,411,198
- SIC
- 2834 PHARMACEUTICAL PREPARATIONS
- Employees
- 1
- Location
- LOS ANGELES, CA
- Homepage
- https://www.kairospharma.com
- Description
Kairos Pharma Ltd is a clinical-stage biopharmaceutical company. The company is engaged in therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance. These therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma. The product portfolio of the company consists of Pre-clinical or clinical-trial stage drug candidates, Therapeutic agents, and other technologies for treating diseases.
Market cap and share counts drift.